Table 2.
Results based on the weight of the experimental studied groups
Groups | Total number of live births | Weight of live births Means ± SD |
|||||
---|---|---|---|---|---|---|---|
|
|
||||||
Male + Female | Male | Female | Male + Female | Male | Female | ||
C1 | 61 | 31 | 30 | 5.85 ± 0.75 | 6.04 ± 0.70 | 5.64 ± 0.76 | |
T1 | 28 | 14 | 14 | 6.29 ± 0.47 | 6.43 ± 0.44 | 6.15 ± 0.47 | |
T2 | 11 | 5 | 6 | 3.38 ± 0.59 | 3.27 ± 0.55 | 3.47 ± 0.66 | |
C2 | 67 | 31 | 36 | 4.02 ± 0.66 | 3.95 ± 0.76 | 4.08 ± 0.57 | |
T3 | 76 | 41 | 35 | 4.07 ± 1.10 | 4.12 ± 1.26 | 4.15 ± 0.91 | |
T4 | 38 | 18 | 20 | 2.23 ± 0.82 | 2.57 ± 0.28 | 1.91 ± 1.02 |
C1: Control group that received no medication. T1: Treated groups receiving 365 mg/kg starting from first day of insemination. T2: Treated groups receiving 365 mg/kg starting from 30 days prior to pregnancy. C2: Control group that received no medication and underwent caesarian section on the 15th day of gestational age. T3: Treated groups receiving 365 mg/kg starting from first day of insemination and underwent caesarian section on the 15th day of gestational age. T4: Treated groups receiving 365 mg/kg starting from 30 days prior to pregnancy and underwent caesarian section on the 15th day of gestational age.